Women's telehealth company Wisp acquires TBD Health
Wisp to add enterprise and hybrid care offering
Wisp has acquired TBD Health, marking the women’s telehealth company’s first acquisition and a strategic move beyond direct-to-consumer care into enterprise and hybrid healthcare models.
The deal adds national clinical infrastructure, diagnostics, and hospital and public health partnerships to Wisp’s platform. Financial terms were not disclosed. Wisp said the acquisition positions the company to deliver care through a mix of digital-first services, health systems, employers, and public health organisations.
“This acquisition reflects where healthcare is going and where women have been left behind,” said Monica Cepak, CEO of Wisp.
“TBD Health brings the infrastructure and partnerships that allow us to move into hybrid and enterprise care quickly, while staying true to Wisp’s patient-first approach.”
Broader care delivery
Founded as a direct-to-consumer women’s health platform, Wisp has built its business around discreet, online access to services including birth control, STI testing, fertility, menopause care, and at-home diagnostics. The acquisition of TBD Health signals a shift toward broader care delivery models that integrate consumer platforms with institutional partners.
Hybrid care models—combining virtual services with in-person diagnostics, labs, and health systems—are becoming increasingly central to how preventive and sexual health care is delivered in the US. Despite wider availability of preventive tools, access gaps remain significant. In HIV prevention, for example, only around 25% of the estimated 2.4 million people eligible for pre-exposure prophylaxis (PrEP) are currently enrolled. Women account for roughly 19% of new HIV diagnoses but remain underserved by existing prevention pathways, which have historically been designed and marketed primarily to men.
Access via TBD
TBD Health operates a nationally scaled sexual health and diagnostics platform across all 50 states, offering routine STI and HIV testing alongside virtual clinical support. The company is also one of the most scaled TelePrEP providers in the US, with established relationships across hospital systems, enterprises, and public health organisations.
Through the acquisition, Wisp gains access to those partnerships, which include organisations such as Mount Sinai Health System, the San Francisco AIDS Foundation, and Planned Parenthood Direct. The combined platform is intended to support sexual health services, diagnostics, and preventive care that can be embedded into existing clinical and operational workflows.
“By joining forces with Wisp, we can provide partners with a turnkey solution for PrEP along with sexual health diagnostics and care that integrates seamlessly into their existing workflows,” said Daphne Chen, co-founder of TBD Health.
Co-founder Stephanie Estey added that Wisp’s scale and brand trust made it well positioned to take TBD Health’s enterprise-focused model further.
"Wisp is the only digital health company with the scale and trust to take our enterprise vision to the next level," she said.
Wisp said the acquisition enables it to serve not only individual patients, but also health systems, employers, and public health programmes seeking scalable sexual health and prevention solutions. The company is now actively pursuing partnerships across the healthcare landscape as it builds out enterprise and hybrid offerings.
More to come from Wisp
Looking ahead, Wisp indicated it will continue to explore additional strategic mergers and acquisitions as part of its growth strategy, including expansion into new health categories and care modalities.
TBD Health was co-founded by Stephanie Estey, Daphne Chen, and Sherwin Lu and was recently named one of Fast Company’s Most Innovative Companies. Wisp serves approximately 1.8 million patients nationwide and is majority-owned by WELL Health Technologies Corp..
The acquisition underscores a broader shift in women’s health toward integrated care models that blend digital access with physical infrastructure—particularly in sexual and preventive health, where convenience, stigma reduction, and continuity of care remain critical barriers to access.